Port
EngCOFEPRIS announces the revocation of advertising criteria and guidelines
Sorry, but you do not have permission to view this content.
22oct
Related Posts
22oct
ANVISA opens public consultation to update the list of over-the-counter medications
On September, ANVISA published in the Journal of the Union... read more
28oct
ILAR participated in the Health Forum and 26th Pharmaceutical Forum of the ANDI, Colombia, held in Cartagena.
This Forum is the space that summons all health actors around... read more
11may
ILAR presente en el evento de la Asociación Mexicana de Medicamentos de Libre Acesso (AFAMELA)
El Director General de ILAR, Juan Thompson, participó el pasado 17... read more
06nov
Reunión del Grupo OTC de ILAR en Washington DC
Los dias 4 y 5 de diciembre 2017, ILAR celebró la... read more
13ago
Brazil: Self-care in times of Covid-19
For the Day of Self-Care ABIMIP with support from ILAR encouraged... read more
22oct
ILAR in Washington DC at the 57th Meeting of the Directing Council of the Pan American Health Organization (PAHO)
ILAR’s Director General Juan Thompson attended the 57th meeting of the... read more
22oct
Brazil establishes automatic conciliation of drug registration that has been authorized by the health authorities of other countries
The bill of law 3847/2019 created by Congress General Paternell (PSL)... read more
13ago
Colombia: ANDI created the campaign “#YoMeCuido”
ANDI created the campaign “YoMeCuido” with different materials that were distributed... read more
13ago
Interviews and Events
Thompson, Executive Director, ILAR participated in webinars and interviews dealing with... read more
29oct
Estudio Revela El Impacto Social Y Económico De Promover El Autocuidado De La Salud En Latinoamérica
La Asociación Regional de Medicamentos de Venta Libre en Latinoamérica,... read more